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Letters to the Editor
Confocal microscopy of idarubicin localisation
Sir
We have read with interest and some surprise the paper recently
published in the British Journal ofCancer: Confocal microscopy
of idarubicin localisation in sensitive and multidrug resistant
bladder cancer cell lines (Br J. Cancer 1996; 74: 906-909) by
Duffy, Hayes, Cooper and Smart, from Southampton.
A factor that has not been taken into account by the authors and
which would significantly modify their conclusions is the fact that
there is a 98% quenching offluorescence when an anthracycline is
intercalated between DNA base pairs. This means that the nuclear
signal of anthracycline fluorescence has to be multiplied by 50 to
be compared with the cytoplasmic nuclear signal. The confocal
microscopic study performed by the authors is in no way quantita-
tive and the rough comparison ofthe visual signals (cytoplasm vs
nuclear) cannot bring any conclusions concerning the subcellular
distribution ofthe drug. The differences pointed outby the authors
between doxorubicin and idarubicin are not sustained by any
quantitative data and cannot be interpreted. We would advise the
authors to use confocal microspectrofluorometry, a technique
that allows absolute measurements of anthracycline nuclear
concentration (Gigli et al, 1988, 1989). Such a technique applied
to idarubicin has already been performed in Reims and has led to
the conclusions that the behaviour ofidarubicin is not qualitatively
different from that ofdoxorubicin or other anthracyclines.
Professeur MManfait
Faculte de Pharmacie,
51, rue Cognacq-Jay,
51096 Reims Cedex
Professeur JRobert
Institut Bergonie,
180, rue de Saint Genes,
33076 Bordeaux
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Confocal microscopy of idarubicin localisation - reply
Sir
Professors Manfait and Robert highlight the difficulty in inter-
preting nuclear/cytoplasmic fluorescence in the presence of
quenching. This is a dilemma addressed in our original article and
our findings regarding this phenomenon are presented in Figure 5.
The data show that differences in fluorescence quenching between
idarubicin and conventional anthracyclines (in free solution with
DNA) appear insufficient to account for the consistent differences
in nuclear/cytoplasmic fluorescence observed in our studies. We
have also more recently repeated the studies using nuclei isolated
from our cell lines by zaponin in the presence of protease and
phosphatase inhibitors. Idarubicin fluoresces in stripped nuclei as
effectively as epirubicin. We will publish these results as soon as
possible in view oftheir relevance to this controversy. Overall, we
feel that we have demonstrated a distinction between intracellular
idarubicin fluorescence and that of less lipophilic anthracyclines
that is not explained by fluorescence quenching phenomena.
P Duffy, MHayes andA Cooper
MDR Research Group Department ofUrology,
Surgery andHaematology,
Mail Point 827,
Southampton General Hospital,
Southampton S016 6YD, UK
Colorectal carcinoma: some reflections on bile flow
through the terminal ileum
Sir
I have just read with great interest the paper by Boutron et al
(1996). They suggest that the type of dairy product might be the
important factor with regard to prevention ofcolorectal tumours.
It is widely believed that bile salts may have some role in
colorectal carcinoma (CRC) (Nagengast, 1988; Garewal et al,
1996). The enzyme diamine oxidase (DAO), which is a major
catabolic enzyme for histamine, is found in highest concentration
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Figure 1 Summary of possible DAO effect in the terminal ileum
in the ileal mucosa (Lessof et al, 1990). DAO is thought to be
involved in the possible inhibition ofcolonic mucosal proliferation
(Kusche et al, 1988). It has been shown that DAO activity can be
reduced in vitro by several factors including detergent (Sattler et
al, 1987), and bile salt (Stoneham et al, 1993). Alcohol has also
been thought to inhibit DAO in vivo (Wantke et al, 1993). There
appears to be a limit to cholesterol solubility in the bile salt micelle
(Chijiwa and Nagai, 1987a,b) that might lead to variable amounts
of free bile salt in the lumen of the terminal ileum with different
dietary fat intakes. These statements are summarized in Figure 1.
Could these mechanisms in vivo go some way to explain the
geographical variations in colorectal cancer incidence that have
been correlated with different regional dietary patterns (Armstrong
and Doll, 1975; Bingham, 1990), and also the possible link with
cholecystectomy? (Ekbom et al, 1993; Giovanni et al, 1993).
Could the possible inhibition of DAO by alcohol help in under-
standing the role of alcohol ingestion in colorectal carcinoma
(Hirayama, 1989)? If the importance of DAO inhibition is estab-
lished in vivo, could the susceptibility of certain families to
colorectal cancer (Petersen, 1995; Winawer et al, 1996) be partly
related to genetic variants ofDAO?
Michael Stoneham
UHCE
Institute ofHealth Sciences
Old Road
Oxford OX3 7LF
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